Doxorubicin liposome Intravenous and Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
Determining the interaction of Doxorubicin liposome Intravenous and Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Ritonavir may increase the blood levels and effects of DOXOrubicin liposomal. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. Contact your doctor if your condition changes or you experience increased side effects. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Coadministration with ritonavir may increase the plasma concentrations of drugs that are substrates of the CYP450 3A4 isoenzyme. The mechanism is decreased clearance due to inhibition of CYP450 3A4 activity by ritonavir. The area under the plasma concentration-time curve (AUC) of some coadministered drugs has been reported to increase by 3-fold or more.
MANAGEMENT: Caution is advised if ritonavir must be used concurrently with medications that undergo metabolism by CYP450 3A4, particularly those with a narrow therapeutic range. Dosage adjustments as well as clinical and laboratory monitoring may be appropriate for some drugs whenever ritonavir is added to or withdrawn from therapy.
- "Product Information. Rapamune (sirolimus)" Wyeth-Ayerst Laboratories, Philadelphia, PA.
- "Product Information. Norvir (ritonavir)." Abbott Pharmaceutical, Abbott Park, IL.
- Olkkola KT, Palkama VJ, Neuvonen PJ "Ritonavir's role in reducing fentanyl clearance and prolonging its half-life." Anesthesiology 91 (1999): 681-5
Generic Name: doxorubicin liposomal
Brand name: Doxil, Lipodox, Lipodox 50
Synonyms: Doxorubicin liposomal, DOXOrubicin (Liposomal)
Generic Name: dasabuvir / ombitasvir / paritaprevir / ritonavir
Brand name: Viekira XR, Viekira Pak
Synonyms: Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets, and Dasabuvir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Doxorubicin liposome Intravenous-Omeclamox-Pak
- Doxorubicin liposome Intravenous-Omega-3 Fatty Acid Capsules
- Doxorubicin liposome Intravenous-Omega-3 Fatty Acids
- Doxorubicin liposome Intravenous-Omega-3 polyunsaturated fatty acids
- Doxorubicin liposome Intravenous-Omega-3-acid ethyl esters
- Doxorubicin liposome Intravenous-Omega-3-carboxylic acids
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Doxy 100
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Doxycycline
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Doxycycline Calcium
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Doxycycline Capsules (Rosacea)
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Doxycycline Capsules with Omega-3 and Vitamin E Capsules
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Doxycycline Delayed Release Capsule